Drug Database
Back to search

Poland· PL-100489382

Cutivate

A fluticasone product containing fluticasoni propionas, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 10 of our 19 countries.

ATC D07AC17

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCutivateATCD07AC17REGISTER NO.PL-100489382PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fluticasoni propionasAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Fluticasone is registered in 10 of 19 countries.

Countries holding a registration under ATC D07AC17 (fluticasone), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search fluticasone products by name

Fluticasone · ATC D07AC17

10 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Fluticasoni propionas
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
D07AC17
ATC class
Fluticasone
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991525064

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

56 interactions on record for fluticasone.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check fluticasone against other medicinesHow interaction checks work

Fluticasone · interactions on record

56 records

  • 1 moderate
  • 55 minor

Most severe, free to view

  • EchinaceaD03AH02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fluticasone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fluticasone products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Flixonase Aquosum, Flixotide Diskus Forte
  • Belgium · Flixonase Aqua, Flixotide
  • Bulgaria · Аркуист, Фликсоназе
  • Cyprus · Cutivate, Flixonase Aqueous
  • Czechia · Flixotide Diskus, Flixotide Inhaler N
  • Germany · Flutica, Fluticason Cipla
  • Denmark · Flixotide, Flurhin
  • Estonia · Cutivate Cream, Flixonase
  • Spain · Avancort, Flixonase
  • Finland · Flixonase, Flixotide Diskus
  • France · Fixorinox, Flixonase
  • United Kingdom (Northern Ireland) · Aeronate, Boots Allergy Relief
  • Greece · Alerxem, Bocacort-S
  • Croatia · Flixonase, Flixotide Inhaler
  • Hungary · Cutivate, Flixonase
  • Ireland · Arquist, Flixonase Allergy Relief
  • Iceland · Avamys, Flixotide
  • Italy · Aktanos, Deflut
  • Liechtenstein · Avamys
  • Lithuania · Cutivate, Flixotide
  • Luxembourg · Flixonase Aqua, Flixotide
  • Latvia · Flixonase, Flixotide
  • Malta · Cutivate, Flihaler
  • Netherlands · Cortifil, Cutivate
  • Norway · Avamys, Flurhin
  • Portugal · Brisovent Diskus, Brisovent Inalador
  • Romania · Arquist, Cutivate
  • Sweden · Arquist, Fluticasone Cipla
  • Slovenia · Flixonase, Flixotide
  • Slovakia · Flixonase Aqueous, Flixotide Diskus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e32ddce4-66b0-4ca0-b7f7-4959f7b09e43
GET /v1/drugs/e32ddce4-66b0-4ca0-b7f7-4959f7b09e43?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krem",
  "source": "urpl",
  "strength": "0,5 mg/g",
  "packaging": "05909991525064 ¦ Rp ¦ 151860\n1 tuba 15 g",
  "substance": "Fluticasoni propionas 0.5 mg/g",
  "common_name": "Fluticasoni propionas",
  "pl_product_id": "100489382",
  "pozwolenie_nr": "244/23",
  "auth_procedure": "IR",
  "authorisation_validity": "2028-10-27"
}
API referenceMCP serverPlans

See everything about fluticasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console